Overbrook Management Corp Immucell Corp Transaction History

Overbrook Management Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$4.85 - $7.84 $12,973 - $20,972	-2,675 Reduced 7.53%	32,857 $169,000
Q2 2022 Aug 11, 2022	SELL	$7.7 - $10.71 $79,648 - $110,784	-10,344 Reduced 22.55%	35,532 $309,000
Q1 2022 May 16, 2022	SELL	$8.0 - $10.06 $236,744 - $297,705	-29,593 Reduced 39.21%	45,876 $443,000
Q4 2021 Feb 14, 2022	SELL	$8.0 - $9.74 $53,248 - $64,829	-6,656 Reduced 8.1%	75,469 $604,000
Q3 2021 Nov 12, 2021	SELL	$8.54 - $10.24 $43,553 - $52,224	-5,100 Reduced 5.85%	82,125 $769,000
Q2 2021 Aug 13, 2021	SELL	$8.5 - $10.95 $1,700 - $2,190	-200 Reduced 0.23%	87,225 $829,000
Q1 2021 May 17, 2021	SELL	$5.98 - $11.88 $3,588 - $7,128	-600 Reduced 0.68%	87,425 $843,000
Q2 2020 Aug 13, 2020	BUY	$3.95 - $4.9 $347,698 - $431,322	88,025 New	88,025 $416,000

1.15M

Ticker ICCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,746,860
Market Cap $28.7M
Description
ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive ...

Get notified when there are updates to the investment portfolio of Overbrook Management Corp, based on Form 13F filings with the SEC.

Stay updated on Overbrook Management Corp with notifications on news.